Benzinga's Top Pre-Market Gainers
Novavax (NASDAQ: NVAX) surged 5.69% to $2.23 in the pre-market session after the company reported positive top-line results from Phase 1 trial of RSV vaccine candidate.
Ceres (NASDAQ: CERE) soared 2.54% to $3.23 in the pre-market trading. Ceres shares have dropped 65.91% over the past 52 weeks, while the S&P 500 index has gained 17.54% in the same period.
Canadian Solar (NASDAQ: CSIQ) shares gained 2.47% to $12.09 in the pre-market session after the company completed the sale of Brockville facility to TransCanada.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.